Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2175 of 3284 entries
View as:

A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06764875 Org: User:
Start: 03/01/25 End: 11/12/30 Due: 11/12/31

A Phase I/IIa Study of AZD8205 Given Alone or in Combination With Anticancer Drugs, in Participants With Advanced or Metastatic Solid Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT05123482 Org: User:
Start: 10/18/21 End: 03/26/27 Due: 03/26/28

Study of AZD5305 When Given in Combination With New Hormonal Agents in Patients With Metastatic Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05367440 Org: User:
Start: 06/02/22 End: 04/10/31 Due: 04/10/32

To Evaluate 24-hr Glucose After OD vs BD AZD1656

Phase: N/A Priority: Normal
NCT ID: NCT00819884 Org: User:
Start: 01/31/09 End: 05/31/09 Due: 05/31/10

Study to Assess the Effect of AZD9291 on the Blood Levels of Rosuvastatin, in Patients With EGFRm+ Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02317016 Org: User:
Start: 03/10/15 End: 05/22/18 Due: 05/22/19

Resistance & Activating Mutations Diagnosed Among NSCLC Community Dwelling EGFR Mutation Positive Patients

Phase: N/A Priority: Normal
NCT ID: NCT03137264 Org: User:
Start: 10/24/17 End: 11/10/18 Due: 11/10/19

Real-World Clinical Experience of Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Olaparib + Abiraterone (PROceed)

Phase: N/A Priority: Normal
NCT ID: NCT06380738 Org: User:
Start: 02/14/24 End: 01/31/27 Due: 01/31/28

Observational Study to Evaluate Bipolar Disorder Symptoms in Patients Presented With Schizophrenia or Depression

Phase: N/A Priority: Normal
NCT ID: NCT01028196 Org: User:
Start: 11/30/09 End: 11/30/10 Due: 11/30/11

Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06535607 Org: User:
Start: 08/22/24 End: 10/07/27 Due: 10/07/28

Study of Undertreatment of Patients With Dyslipidemia in Bulgaria

Phase: N/A Priority: Normal
NCT ID: NCT01075594 Org: User:
Start: 02/28/10 End: 08/31/10 Due: 08/31/11

Esomeprazole for Relief of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs

Phase: N/A Priority: Normal
NCT ID: NCT00241540 Org: User:
Start: 01/31/01 End: 08/31/02 Due: 08/31/03

Ascending Doses of Ceralasertib in Combination With Chemotherapy and/or Novel Anti Cancer Agents

Phase: N/A Priority: Normal
NCT ID: NCT02264678 Org: User:
Start: 10/31/14 End: 12/31/25 Due: 12/31/26

Patient's Anastrozole Compliance to Therapy Programme

Phase: N/A Priority: Normal
NCT ID: NCT00555867 Org: User:
Start: 10/31/06 End: 02/28/11 Due: 02/28/12

A Comparative Efficacy and Safety Study of Nexium Delayed-Release Capsules (40mg qd and 20mg qd) Versus Ranitidine 150mg Bid for the Healing of NSAID-Associated Gastric Ulcers When Daily NSAID Use is Continued in Subjects in the US Only

Phase: N/A Priority: Normal
NCT ID: NCT00633412 Org: User:
Start: 02/28/01 End: 03/31/03 Due: 03/31/04

Mobile Devices to Detect Early Pneumonitis in Stage III NSCLC Patients on Durvalumab.

Phase: N/A Priority: Normal
NCT ID: NCT04381494 Org: User:
Start: 04/27/20 End: 01/27/22 Due: 01/27/23

To Determine the Effect of Food on the Pharmacokinetics of Olaparib and the Effect of Olaparib on QT Interval Following Oral Dosing of a Tablet Formulation in Patients With Advanced Solid Tumours

Phase: N/A Priority: Normal
NCT ID: NCT01921140 Org: User:
Start: 09/24/13 End: 03/15/22 Due: 03/15/23

PULSAR - A Prospective Study to Evaluate the Utility of Low Doses of the Statins Atorvastatin and Rosuvastatin.

Phase: N/A Priority: Normal
NCT ID: NCT00329173 Org: User:
Start: 11/30/03 End: 08/31/04 Due: 08/31/05

Effect of Quetiapine on Negative Symptoms and Cognition

Phase: N/A Priority: Normal
NCT ID: NCT00305422 Org: User:
Start: 11/30/01 End: 01/31/03 Due: 01/31/04

Open Label Extension Study With Gefitinib (IRESSA™) for Completing Trial Patients Who May Benefit From Further Treatment

Phase: N/A Priority: Normal
NCT ID: NCT00683306 Org: User:
Start: - End: - Due: -

Phase I Study to Assess the Effect on Healthy Male Volunteers of Ketoconazole on the Pharmacokinetics of a Single Dose of AZD5069 Administered Orally.

Phase: N/A Priority: Normal
NCT ID: NCT01735240 Org: User:
Start: 12/31/12 End: 02/28/13 Due: 02/28/14

A Study Conducted Over 3 Periods to Look at the Drug in the Body

Phase: N/A Priority: Normal
NCT ID: NCT01225939 Org: User:
Start: 11/30/10 End: 12/31/10 Due: 12/31/11

Seroquel Switching Study: Feasibility of Switching Any Antipsychotic Treatment to Seroquel in Patients With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT00234377 Org: User:
Start: 11/30/04 End: 05/31/06 Due: 05/31/07

A Study to Assess the Bioequivalence of Dapagliflozin/Metformin XR Fixed-dose Combination Tablets in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02637037 Org: User:
Start: 12/21/15 End: 04/07/16 Due: 04/07/17

A Study to Evaluate Cortisol Reserve in Response to Adrenocorticotropic Hormone (ACTH) Stimulation Test Following Baxdrostat Treatment Compared to Placebo in Participants With Uncontrolled Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT06336356 Org: User:
Start: 06/10/24 End: 12/04/24 Due: 12/04/25

Study of Olaparib (Lynparza™) Versus Enzalutamide or Abiraterone Acetate in Men With Metastatic Castration-Resistant Prostate Cancer (PROfound Study)

Phase: N/A Priority: Normal
NCT ID: NCT02987543 Org: User:
Start: 02/06/17 End: 02/15/23 Due: 02/15/24